Observation of the effect of targeted therapy of 64-slice spiral CT combined with cryoablation for liver cancer

Abstract

AIMTo observe the effect of targeted therapy with 64-slice spiral computed tomography (CT) combined with cryoablation for liver cancer.METHODSA total of 124 patients (142 tumors) were enrolled into this study. According to the use of dual-slice spiral CT or 64-slice spiral CT as a guide technology, patients were divided into two groups: dual-slice group (n = 56, 65 tumors) and 64-slice group (n = 8, 77 tumors). All patients were accepted and received targeted therapy by an argon-helium superconducting surgery system. The guided scan times of the two groups was recorded and compared. In the two groups, the lesion ice coverage in diameter of ≥ 3 cm and < 3 cm were recorded, and freezing effective rate was compared. Hepatic perfusion values [hepatic artery perfusion (HAP), portal vein perfusion (PVP), and the hepatic arterial perfusion index (HAPI)] of tumor tissues, adjacent tissues and normal liver tissues at preoperative and postoperative four weeks in the two groups were compared. Local tumor changes were recorded and efficiency was compared at four weeks post-operation. Adverse events were recorded and compared between the two groups, including fever, pain, frostbite, nausea, vomiting, pleural effusion and abdominal bleeding.RESULTSGuided scan times in the dual-slice group was longer than that in the 64-slice group (t = 11.445, P = 0.000). The freezing effective rate for tumors < 3 cm in diameter in the dual-slice group (81.58%) was lower than that in the 64-slice group (92.86%) (χ2 = 5.707, P = 0.017). The HAP and HAPI of tumor tissues were lower at four weeks post-treatment than at pre-treatment in both groups (all P < 0.05), and those in the 64-slice group were lower than that in the dual-slice group (all P < 0.05). HAP and PVP were lower and HAPI was higher in tumor adjacent tissues at post-treatment than at pre-treatment (all P < 0.05). Furthermore, the treatment effect and therapeutic efficacy in the dual-slice group were lower than the 64-slice group at four weeks post-treatment (all P < 0.05). Moreover, pleural effusion and intraperitoneal hemorrhage occurred in patients in the dual-slice group, while no complications occurred in the 64-slice group (all P < 0.05).CONCLUSION64-slice spiral CT applied with cryoablation in targeted therapy for liver cancer can achieve a safe and effective freezing treatment, so it is worth being used.

Meta-analysis of transarterial chemoembolization combined with cryoablation vs transarterial chemoembolization alone for ≥ 5 cm hepatocellular carcinoma

“…CRA is associated with minimal trauma, significant therapeutic effects, and fewer postoperative complications, especially in the treatment of small liver cancer, which yields satisfactory results. Current research has shown that for early liver cancer patients with tumors < 3 cm, CRA ablation therapy can be an alternative to surgery[ 17 ]. However, the use of CRA for the treatment of liver cancer patients with lesions ≥ 5 cm has limitations.…”

Advances in the interventional therapy of hepatocellular carcinoma originating from the caudate lobe

“… 54 The use of multi-slice spiral CT guidance to improve efficacy and reduce complications has been suggested in a study. 55 The use of MRI-CT fusion imaging to evaluate cryoablation margins in hepatocellular carcinoma has also been suggested. 56 Despite the lack of clinical studies on cryoablation of caudate lobe HCC, cryoablation has shown very good potential application for the treatment thereof.…”

System analysis based on the lysosome-related genes identifies HPS4 as a novel therapy target for liver hepatocellular carcinoma

“…The number of patients who die from LIHC each year exceeds half a million ( 4 ). In the early stages, LIHC has no symptoms but rapidly progresses ( 5 ). At present, LIHC is mainly treated with liver transplantation, hepatic resection, and medication ( 6 ).…”